Gout
📧 Sign up to get email alerts when something new happens for Gout.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
A Strasbourg-based study is evaluating whether physician consideration of electronic patient-reported outcomes from patients with gout, rheu…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Clinical Study of Genakumab for Injection in Patients With Acute Gout [Phase 1, Phase 2]
The document reports a completed Phase 1/Phase 2 clinical study of Genakumab for injection in patients with acute gout, conducted by Changch…
-
FDA approval · 2025-02-15FDA Approved: NAPROXEN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Naproxen (ANDA074190) from Hikma Pharmaceuticals USA Inc., resulting in an updated approval of t…
-
FDA approval · 2025-02-11FDA Approved: ALLOPURINOL — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Allopurinol from Accord Healthcare Inc., indicating an additional approval for the generic produ…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of PRX-115 in adults with elevated uric acid levels (g…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Rural Home Hospital: Proof of Concept [NA]
Completed clinical trial update for Rural Home Hospital: Proof of Concept with results posted.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout [Phase 2]
A Phase 2 clinical trial update evaluating AR882 alone or in combination with allopurinol for tophaceous gout has completed, focusing on eff…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia [Phase 1, Phase 2]
This open-label PK, PD, and DDI study evaluated dotinurad in combination with allopurinol in gout patients with hyperuricemia and has comple…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout [Phase 3]
A Phase 3 multicenter, randomized, double-blind trial evaluating the efficacy and safety of SHR4640 in gout with allopurinol as a comparator…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate [Phase 4]
Phase 4 trial evaluating the tolerability of pegloticase (Krystexxa) given with a shorter infusion duration in subjects with uncontrolled go…
-
CLINICAL_TRIALS trial_result · 2025-01-01Clinical Trial Update: A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202) [Phase 2]
A completed Phase 2 trial evaluating the efficacy of Genakumab to prevent acute gout flares in patients initiating urate-lowering therapy.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Safety & Efffficacy of Genakumab in Patients With Frequent Flares [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of Genakumab in patients with frequent flares of acute gout arthritis has been completed.
-
FDA approval · 2024-12-12FDA Approved: COLCHICINE — Supplemental Application (Granules Pharmaceutical Inc.)
The FDA approved a supplemental application for Colchicine from Granules Pharmaceutical Inc., updating the approved Colchicine product.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function [Phase 1, Phase 2]
This clinical trial update describes pharmacokinetic and safety evaluation of SAP-001 in adult subjects with normal and impaired renal funct…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: The Remote Monitoring of Gout Feasibility Study [NA]
The remote monitoring feasibility study for gout has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Genetic of Chronic Kidney Disease and Gout in New Caledonia [NA]
A completed clinical trial sponsored by Lille Catholic University investigated genetic factors in chronic kidney disease and gout in New Cal…
-
FDA approval · 2024-11-21FDA Approved: DICLOFENAC SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for a generic diclofenac sodium product from NorthStar Rx LLC.
-
FDA approval · 2024-11-21FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves a supplemental application for Indomethacin from Amneal Pharmaceuticals LLC (ANDA 091549), authorizing a supplemental change to…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001. [Phase 2]
A Phase 2 dose-finding clinical trial assessing three dosages of SAP 001 for gout; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese Subjects [Phase 1]
Phase 1 SAD/MAD and food-effect study of SAP-001 tablets in Chinese subjects has completed. Sponsor: Shanton Pharma Co., Ltd.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of Genakumab injections in patients with gout flare has completed, reporting safety and e…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory Gout [NA]
This clinical trial aims to evaluate the efficacy and safety of thermotherapy for refractory gout. Recruitment has not yet started.
-
FDA approval · 2024-10-11FDA Approved: COLCHICINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Colchicine from Camber Pharmaceuticals, Inc., resulting in an approved change to an existing…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: The Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More [Phase 4]
Phase 4 clinical trial assessing whether tapering febuxostat dosing is safe and effective in gout patients who have had uric acid control fo…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating AR882 capsules versus febuxostat tablets in adults with primary gout and hyperuricemia; the study i…